THE VALUE OF URINARY CYTOLOGY AND HYDRONEPHROSIS TO PREDICT MUSCLE INVASIVE BLADDER CANCER
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: We evaluated the value of urinary cytology, and presence of hydronephrosis to predict muscle invasive bladder cancer. Material & methods: We retrospectively analyzed data of 167 patients that diagnosed bladder cancer from medical record at Sardjito General Hospital Yogyakarta, between 2004-2011. Preoperative parameters were evaluated including age, gender, number and location of bladder cancer, urinary cytology, as well as presence of hydronephrosis. The outcome was muscle invasive bladder cancer. Results: A total of 96 (57.5%) patients had positive urinary cytology, 80 (47.9%) had hydronephrosis, most location of tumor were in trigone 43 (25.7%). The youngest patient was 26 years and the oldest was 84 years old, male was most affected in 145 (86.8%). On bivariate analysis, positive urinary cytology and hydronephrosis were associated with muscle invasive bladder cancer (OR 0.08 CI 0.038–0.167; OR 30.24 CI 12.72–71.89, respectively, each p < 0.05). Combination urinary cytology and hydronephrosis incrementally improved prediction of muscle invasive bladder cancer with positive and negative predictive value were 93.9% and 71.4%, respectively. Presence of hydronephrosis was associated with tumor location in trigone (p < 0.05). Conclusion: Urinary cytology and hydronephrosis were associated with muscle invasive bladder cancer, and can be used to predict muscle invasive bladder cancer.
##plugins.themes.bootstrap3.article.details##
Urinary cytology, hydronephrosis, muscle invasive bladder cancer
David P, Wood. Urothelial tumour of the bladder, in Campbell-Walsh Urology. 10th ed. Saunders: Philadelphia USA. p. 2311.
Stenzl, Witjes. Guideline on bladder cancer muscle-invasive and metastatic. EAU; 2012.
John P, Gary L. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. Los Angeles. Journal of Clinical Oncology. 2001; 19(3): 666-75.
Rene, Cury. Conservative treatment of invasive bladder cancer. Montreal: Current Oncology. 2009; 16(4).
Stephen J, William A. Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS), in Campbell-Walsh Urology. 10th ed. Saunders: Philadelphia USA. p. 2381.
Jimie M, Shahrokh F. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. Dallas: BJU Int. 2011; 108: 701-5.
James C, Shahrokh. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma; 2010.
Evelyne C, Jean J. Bladder cancer in practical urology essential principle. Springer: London; 2011. p. 512.
Parag G. Impact of age and gender on the clinicopathological characteristics of bladder cancer. India: Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences; 2009.
Donald G. Cancer of the bladder in adult and pediatric urology. 4th ed. Virginia: William and Wilkins; 2002. p. 2255.
Nandakishore S. Predicting the risk of high-grade bladder cancer using noninvasive data. Karger, Jurusalem. Urol Int. 2011; 87: 319–24.